Your session is about to expire
← Back to Search
BI 836880 for Age-Related Macular Degeneration
Study Summary
This trialwill assess how well different doses of a medicine called BI 836880 are tolerated to treat wet age-related macular degeneration (wAMD). Participants receive the medicine injected into their eyes and are monitored over 6 weeks or 6 months.
- Age-Related Macular Degeneration (AMD)
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are a man or woman who is 55 years or older and have a new case of blood vessels growing in the wrong place in your eyes due to age-related macular degeneration (AMD) and have not received any previous treatment for it.People who are 55 years or older and have been diagnosed with age-related macular degeneration (AMD).You are a patient with treatment-resistant wet age-related macular degeneration (wAMD).You have other eye diseases in the study eye that could affect your vision, such as visual field loss, uncontrolled glaucoma, diabetic maculopathy, or certain genetic disorders. You also have a history of high myopia in the study eye. There are abnormalities in the front part of your eye or in the gel-like substance inside your eye that would make it difficult to observe using a special imaging technique called SD-OCT.This part of the study is for patients who have not received any previous treatment for wet age-related macular degeneration (wAMD).
- Group 1: BI 836880
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you provide me with a figure of the total participants in this research venture?
"Affirmative. Records hosted on clinicaltrials.gov indicate that this medical study, which first appeared June 27th 2019, is actively enrolling patients. A total of 42 people need to be recruited from 8 different centres."
How widespread is the implementation of this research project?
"Participants for this clinical trial are being recruited from Retina Institute of California Medical Group in Palm Desert, Cumberland Valley Retina Consultants, PC. in Hagerstown and Retina Consultants of Texas located in Bellaire plus 8 other sites."
Are researchers still inviting participants to join this investigation?
"According to the clinicaltrials.gov webpage, this medical trial is actively enrolling patients; it was first posted on June 27th 2019 and most recently modified on November 30th 2022."
Share this study with friends
Copy Link
Messenger